CONFIRM: a double-blind, placebo controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial

Fennell, D.A., Kirkpatrick, E., Cozens, K. et al. (13 more authors) (2018) CONFIRM: a double-blind, placebo controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial. TRIALS, 19. 233. ISSN 1745-6215

Abstract

Metadata

Authors/Creators:
  • Fennell, D.A.
  • Kirkpatrick, E.
  • Cozens, K.
  • Nye, M.
  • Lester, J.
  • Hanna, G.
  • Steele, N.
  • Szlosarek, P.
  • Danson, S.
  • Lord, J.
  • Ottensmeier, C.
  • Barnes, D.
  • Hill, S.
  • Kalevras, M.
  • Maishman, T.
  • Griffiths, G.
Copyright, Publisher and Additional Information: © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Keywords: Mesothelioma; PD-L1; Anti-PD-1; Nivolumab; Randomised controlled trial; Quality of life; Overall survival; Placebo; Intention to treat
Dates:
  • Accepted: 15 March 2018
  • Published: 18 April 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 22 May 2018 14:59
Last Modified: 23 May 2018 08:09
Published Version: https://doi.org/10.1186/s13063-018-2602-y
Status: Published
Publisher: BioMed Central
Refereed: Yes
Identification Number: https://doi.org/10.1186/s13063-018-2602-y
Related URLs:

Share / Export

Statistics